NCT00787878View on ClinicalTrials.gov

Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects

CompletedOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Foetal Growth ProblemSmall for Gestational Age
Interventions
DRUG

somatropin

SGA previously treated with Norditropin®

DRUG

No treatment given

Untreated SGA

DRUG

No treatment given

AGA (Average gestational age)

Trial Locations (1)

3015 CN

Novo Nordisk Investigational Site, Rotterdam

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00787878 - Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects | Biotech Hunter | Biotech Hunter